Announced Tue, 8 Apr · 11:18 IST
Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Compliance View source PDF
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Aarti Pharmalabs Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing related to the company's dealings with depositories such as NSDL and CDSL. The announcement does not contain any financial figures or operational details. It is a standard regulatory disclosure with no material business impact.
Likely market impact
This is a routine regulatory compliance filing with no expected impact on the company's financials, operations, or share price.